NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Adam Leach
Institute of Cancer Research University of London - London / United Kingdom
Others
AD Scientific Index ID: 5912443
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Adam Leach's MOST POPULAR ARTICLES
1-)
A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infectionA Miller, A Leach, J Thomas, C McAndrew, E Bentley, G Mattiuzzo, L John, ...Scientific Reports 11 (1), 10617, 2021362021
2-)
Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculatureA Leach, P Smyth, L Ferguson, J Steven, MK Greene, CM Branco, ...Nanoscale 12 (27), 14751-14763, 2020172020
3-)
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potencyA Leach, FT Ilca, Z Akbar, M Ferrari, EM Bentley, G Mattiuzzo, S Onuoha, ...Antiviral Research 194, 105147, 2021132021
4-)
Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteinsA Leach, A Miller, E Bentley, G Mattiuzzo, J Thomas, C McAndrew, ...Scientific Reports 11 (1), 10475, 202192021
5-)
Enhanced target-specific delivery of docetaxel-loaded nanoparticles using engineered T cell receptorsWJ McDaid, N Lissin, E Pollheimer, M Greene, A Leach, P Smyth, G Bossi, ...Nanoscale 13 (35), 15010-15020, 202192021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept